Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) EBIT Margin (2016 - 2024)

Historic EBIT Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 28776.47%.

  • vTv Therapeutics' EBIT Margin changed N/A to 28776.47% in Q4 2024 from the same period last year, while for Sep 2025 it was 175382.35%, marking a year-over-year decrease of 1729828500.0%. This contributed to the annual value of 2377.58% for FY2024, which is N/A changed from last year.
  • vTv Therapeutics' EBIT Margin amounted to 28776.47% in Q4 2024.
  • vTv Therapeutics' EBIT Margin's 5-year high stood at 28.6% during Q4 2020, with a 5-year trough of 123433.33% in Q4 2021.
  • Moreover, its 4-year median value for EBIT Margin was 34616.81% (2024), whereas its average is 37016.52%.
  • In the last 5 years, vTv Therapeutics' EBIT Margin skyrocketed by 912857400bps in 2020 and then crashed by -1234619300bps in 2021.
  • Over the past 4 years, vTv Therapeutics' EBIT Margin (Quarter) stood at 28.6% in 2020, then tumbled by -431712bps to 123433.33% in 2021, then skyrocketed by 43bps to 70477.78% in 2022, then skyrocketed by 59bps to 28776.47% in 2024.
  • Its EBIT Margin was 28776.47% in Q4 2024, compared to 562.7% in Q1 2024 and 70477.78% in Q4 2022.